CMS Energy Announces Third Quarter Results, Reaffirms 2026 and 2027 Adjusted EPS Guidance

CMS Energy reported Q3 2026 adjusted EPS of $1.44, up from $0.93 a year earlier, while GAAP EPS fell to $0.39 from $0.92, reflecting $1.45 per share of NorthStar Clean Energy impairment and restructuring impacts. Year-to-date adjusted EPS was $2.95 versus $2.66 in 2025. The company reaffirmed 2026 adjusted EPS guidance of $3.83–$3.90, 2027 guidance of $4.08–$4.17, and long-term adjusted EPS growth of 6%–8%, with confidence toward the high end.

Analysis

The key issue is earnings quality, not the headline adjusted-EPS growth: a large NorthStar add-back makes reported results difficult to interpret, while the unusually large noncontrolling-interest attribution swing adds another layer between consolidated operations and common shareholders. The restructuring could improve CMS’s utility-focused profile, but the claim of stronger earnings quality is not yet demonstrated; the asset-sale perimeter, proceeds, retained obligations, and recurring NorthStar losses matter more than the adjusted-EPS bridge.

Near term, reaffirmed guidance should limit estimate risk, but the call is the catalyst for determining whether the disposal actually reduces earnings volatility and financing needs. Over 1–3 months, monitor sale execution and any revisions to capital spending, financing, or the 2027 outlook. Structurally, a more regulated utility mix may merit a steadier multiple, but CMS’s investment program remains capital-intensive: year-to-date investing outflow exceeded operating cash generation, and debt/finance leases rose. Higher rates or regulatory lag could therefore offset the benefit of a cleaner portfolio.

Contrarian point: investors may treat restructuring charges as wholly nonrecurring and focus on adjusted growth. Repeated exclusions, continued NorthStar exposure, or persistent dilution would weaken that case. With no valuation or market-price context supplied, this is a conditional relative-value setup rather than an outright high-conviction buy.

Key Decisions for Investors

• Prefer a measured long CMS versus a broad utilities basket only on post-call weakness, conditional on management clarifying NorthStar assets being sold, expected proceeds, retained liabilities, and the effect on recurring earnings. Reassess if 2027 guidance is cut or sale execution slips.
• Do not capitalize the adjusted-EPS trajectory at face value yet. Track reported-to-adjusted reconciliation, NorthStar-related exclusions, noncontrolling-interest attribution, and diluted share count in the next results; recurring add-backs or further dilution falsify the earnings-quality thesis.
• Watch financing and regulatory execution over the next 6–18 months: rising debt alongside investment outflows leaves CMS exposed to higher borrowing costs and delayed cost recovery. A sustained rise in funding costs or weaker allowed-return outcomes would favor reducing the relative long.
• Use the earnings webcast as the immediate catalyst check; absent concrete disposal economics and confirmation that capital needs remain funded within guidance, there may be no compelling trade beyond a modest relative-value watch.